Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Rev Med Pharmacol Sci ; 18(1): 34-8, 2014.
Article in English | MEDLINE | ID: mdl-24452939

ABSTRACT

BACKGROUND AND AIMS: Renal ischemia followed by reperfusion causes remote liver injury. This research was planned to investigate whether 3-aminobenzamide (3-AB), has any preventive effect against distant liver injury triggered by renal IR. MATERIALS AND METHODS: Twenty four rats were randomly divided into three different groups Each group has 8 rats. The groups were as follows: (1) Sham operated group; (2) Renal ischemia-reperfusion (IR) group; (3) Renal IR+ 3-AB group. 3-AB (10 mg/kg) was given intraperitoneally 10 minute before reperfusion. At the end of study, the rats were sacrificed. Their liver tissues and serum samples were collected for measurement of malondialdehyde (MDA) levels, total oxidant status (TOS), total antioxidant status (TAS), paraoxonase (PON-1) activity and nitric oxide (NO). RESULTS: Renal IR injury significantly increased Oxidative stress index (OSI) and MDA, TOS levels and significantly decreased PON-1 actvity and TAS, NO levels in serum and liver tissue (p < 0.05). Despite that, changes in these biochemical parameters related with IR injury were diminished by 3-AB administration (p < 0.05). CONCLUSIONS: The inhibition of PARP [Poly(ADP-Ribose)Polymerase] by 3-AB showed protective effects against distant liver injury triggered by renal ischemia-reperfusion by the ameliorating effects of 3-AB on oxidative stress.


Subject(s)
Benzamides/therapeutic use , Kidney Diseases/drug therapy , Liver Diseases/drug therapy , Poly(ADP-ribose) Polymerase Inhibitors , Protective Agents/therapeutic use , Reperfusion Injury/drug therapy , Animals , Aryldialkylphosphatase/blood , Aryldialkylphosphatase/metabolism , Benzamides/pharmacology , Kidney Diseases/blood , Kidney Diseases/complications , Kidney Diseases/metabolism , Liver/drug effects , Liver/metabolism , Liver Diseases/blood , Liver Diseases/etiology , Liver Diseases/metabolism , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Nitric Oxide/blood , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Protective Agents/pharmacology , Rats, Wistar , Reperfusion Injury/blood , Reperfusion Injury/complications , Reperfusion Injury/metabolism
2.
Eur Rev Med Pharmacol Sci ; 15(10): 1111-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22165670

ABSTRACT

OBJECTIVE: Although migraine has been related with an increased risk for ischemic stroke and cardiovascular events, there is insufficient data for role of pro-brain natriuretic peptide (pro-BNP) in migraine. In present case-control study, serum levels of pro-inflammatory (TNF-alpha, IL-1beta and IL-6) and anti-inflammatory cytokines (IL-2, and IL-10) of migraine patients were investigated to determine the role of cytokines and pro-BNP in migraine. PATIENTS AND METHODS: Sixty-four consecutive newly diagnosed migraine patients and 34 healthy controls were enrolled. Serum TNF-alpha, IL-1beta, IL-2, IL-6, IL-10 and pro-BNP levels were measured by using a chemiluminescence assay. RESULTS: Migraine patients had significantly higher concentrations of IL-1beta and IL-6 compared with the healthy controls (for IL-1beta; 5.73 +/- 1.44 vs. 4.90 +/- 1.40 pg/mL, respectively, p = 0.006; for IL-6; 3.1 +/- 1.44 vs. 2.40 +/- 0.22 pg/mL, respectively, p = 0.007). The mean IL-10 levels were found to be significantly lower in migraine patients (3.38 +/- 2.93 pg/mL) than controls (6.76 +/- 1.48 pg/mL) (p = 0.007). There were no differences in TNF-alpha (27.2 +/- 48.1 vs. 15.4 +/- 0.7) and IL-2 (1017 +/- 661 vs. 1153 +/- 228) levels between patients with migraine and healthy controls. Migraine patients had higher concentrations of pro-BNP compared with healthy controls (27.0 +/- 28.0 versus 13.2 +/- 8.6, p = 0.006). CONCLUSIONS: Migraine patients have higher serum IL-1beta and IL-6 levels, and lower IL-10 levels than healthy subjects. These findings support that cytokines may be related to neurogenic inflammation in the pathogenesis of migraine. Also, increased pro-BNP may indicate to preclinical cardiac involvement in patients with migraine.


Subject(s)
Cytokines/blood , Migraine Disorders/etiology , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Adolescent , Adult , Biomarkers , Female , Humans , Male , Middle Aged , Migraine Disorders/blood
3.
Ann Rheum Dis ; 63(11): 1504-6, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15479904

ABSTRACT

OBJECTIVES: To investigate abnormalities of the hypothalamic-pituitary-gonadal (HPG) axis and cortisol concentrations in young women with primary fibromyalgia (FM); and to determine whether depression, fatigue, and sleep disturbance affect these hormones. METHODS: Follicle stimulating hormone (FSH), luteinising hormone (LH), oestradiol, progesterone, prolactin, and cortisol concentrations in 63 women with FM were compared with those in 38 matched healthy controls; all subjects aged <35 years. The depression rate was assessed by the Beck Depression Inventory (BDI) and patients with high and low BDI scores were compared. Additionally, patients were divided according to sleep disturbance and fatigue and compared both with healthy controls and within the group. RESULTS: No significant differences in FSH, LH, oestradiol, prolactin, and progesterone levels were found between patients with FM and controls, but cortisol levels were significantly lower in patients than in controls (p<0.05). Cortisol levels in patients with high BDI scores, fatigue, and sleep disturbance were significantly lower than in controls (p<0.05). Correlation between cortisol levels and number of tender points in all patients was significant (r = -0.32, p<0.05). CONCLUSION: Despite low cortisol concentrations in young women with FM, there is no abnormality in HPG axis hormones. Because fatigue, depression rate, sleep disturbance, and mean age of patients affect cortisol levels, these variables should be taken into account in future investigations.


Subject(s)
Fibromyalgia/blood , Gonadal Steroid Hormones/blood , Gonadotropins, Pituitary/blood , Hydrocortisone/blood , Adult , Analysis of Variance , Case-Control Studies , Depression/complications , Estradiol/blood , Fatigue/complications , Female , Fibromyalgia/complications , Fibromyalgia/physiopathology , Follicle Stimulating Hormone/blood , Humans , Hypothalamo-Hypophyseal System/physiopathology , Luteinizing Hormone/blood , Ovary/physiopathology , Progesterone/blood , Prolactin/blood , Sleep Wake Disorders/complications
4.
Int J Clin Pract ; 58(4): 327-32, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15161114

ABSTRACT

There has been considerable interest in the role of hormones in the aetiopathogenesis of rheumatoid arthritis (RA). In this study, we aimed to investigate sex and thyroid hormone conditions according to menopausal state and disease activation in RA women. Fifty-four women with RA were included in the study. Age-matched 28 women with low back pain were used as controls. Sex and thyroid hormones were evaluated in all patients, which included the measurement of estradiol (E2), progesterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, thyroid-stimulating hormone (TSH), total (T) and free (F) triiodothyronine (T3) and (T) and (F) thyroxine (T4). The RA patients were subdivided according to their pre-menopausal and post-menopausal status and their disease activation conditions. Mean age was 45.68 (+/-12.5) in women (aged 22-70) with RA and 42.39 (+/-12.45) in controls (aged 22-62). There were no significant differences in sex hormones, but there were statistically significant higher levels of TT3 and TT4 in whole women with RA compared to controls. Lower concentrations of FSH were detected in active RA patients. There were statistically lower concentrations of LH and higher concentrations of TT3 and TT4 in pre-menopausal RA women, while lower concentrations of FSH were detected in post-menopausal RA women. TT3 and FT3 levels of pre-menopausal RA women were significantly higher than post-menopausal RA women. There were no significant differences for all other hormones studied. In conclusion, sex and thyroid hormones have been influenced in women with RA. Reproductive and menopausal conditions should be taken into consideration when sex and thyroid hormones studies are carried out in RA women.


Subject(s)
Arthritis, Rheumatoid/etiology , Gonadal Steroid Hormones/physiology , Menopause/physiology , Thyroid Hormones/physiology , Adult , Aged , Arthritis, Rheumatoid/blood , Case-Control Studies , Female , Gonadal Steroid Hormones/blood , Humans , Menopause/blood , Middle Aged , Thyroid Hormones/blood
6.
Med Oncol ; 18(1): 51-7, 2001.
Article in English | MEDLINE | ID: mdl-11778970

ABSTRACT

Serum levels of interleukin-1 beta (IL-1beta), soluble interleukin 2 receptors (sIL-2R), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha) were measured to predict some characteristics of febrile episodes in children with cancer and neutropenia. Forty-eight episodes of febrile neutropenia were determined in 23 pediatric cancer patients, including 35 febrile episodes without identifiable source, 7 episodes of bacteremia due to Gram-negative organisms and 4 due to Gram-positive organisms, and 2 fungal infections. Interleukin-6, sIL-2R, and IL-8 levels were significantly higher at the beginning of the febrile episodes than those of controls (p < 0.001, p < 0.001, and p < 0.001). Interleukin-6, slL-2R, and IL-8 levels were higher in patients with bacteremia due to Gram-negative organisms than in those with Gram-positive ones (p = 0.042, p = 0.006, and p = 0.023, respectively). TNF-alpha and IL-1beta levels were similar in febrile episodes and controls (p > 0.05). In conclusion, sIL-2R, IL-6, and IL-8 levels may be helpful in the prediction of infection in febrile cancer patients with neutropenia and measurements of IL-1beta and TNF-alpha were not useful for identifying the presence and the type of infection in febrile neutropenic episodes in children.


Subject(s)
Cytokines/blood , Fever/complications , Gram-Negative Bacterial Infections/etiology , Gram-Positive Bacterial Infections/etiology , Neoplasms/drug therapy , Neutropenia/complications , Adolescent , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Child , Child, Preschool , Female , Fever/chemically induced , Gram-Negative Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/diagnosis , Humans , Infant , Male , Neoplasms/complications , Neutropenia/chemically induced , Predictive Value of Tests , Prognosis , Prospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL